These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1036 related articles for article (PubMed ID: 33713492)

  • 1. Drug repositioning to target NSP15 protein on SARS-CoV-2 as possible COVID-19 treatment.
    Sixto-López Y; Martínez-Archundia M
    J Comput Chem; 2021 May; 42(13):897-907. PubMed ID: 33713492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Docking and Virtual Screening Based Prediction of Drugs for COVID-19.
    Talluri S
    Comb Chem High Throughput Screen; 2021; 24(5):716-728. PubMed ID: 32798373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacoinformatics approach based identification of potential Nsp15 endoribonuclease modulators for SARS-CoV-2 inhibition.
    Savale RU; Bhowmick S; Osman SM; Alasmary FA; Almutairi TM; Abdullah DS; Patil PC; Islam MA
    Arch Biochem Biophys; 2021 Mar; 700():108771. PubMed ID: 33485847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-throughput screening of the ReFRAME, Pandemic Box, and COVID Box drug repurposing libraries against SARS-CoV-2 nsp15 endoribonuclease to identify small-molecule inhibitors of viral activity.
    Choi R; Zhou M; Shek R; Wilson JW; Tillery L; Craig JK; Salukhe IA; Hickson SE; Kumar N; James RM; Buchko GW; Wu R; Huff S; Nguyen TT; Hurst BL; Cherry S; Barrett LK; Hyde JL; Van Voorhis WC
    PLoS One; 2021; 16(4):e0250019. PubMed ID: 33886614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-targeting approach for nsp3, nsp9, nsp12 and nsp15 proteins of SARS-CoV-2 by Diosmin as illustrated by molecular docking and molecular dynamics simulation methodologies.
    Kumar S; Sharma PP; Upadhyay C; Kempaiah P; Rathi B; Poonam
    Methods; 2021 Nov; 195():44-56. PubMed ID: 33639316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of potential target endoribonuclease NSP15 inhibitors of SARS-COV-2 from natural products through high-throughput virtual screening and molecular dynamics simulation.
    Hu LC; Ding CH; Li HY; Li ZZ; Chen Y; Li LP; Li WZ; Liu WS
    J Food Biochem; 2022 May; 46(5):e14085. PubMed ID: 35128681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of potential inhibitors against SARS-CoV-2 endoribonuclease: RNA immunity sensing.
    Al-Rashedi NAM; Munahi MG; Ah ALObaidi L
    J Biomol Struct Dyn; 2022 Jul; 40(11):4879-4892. PubMed ID: 33357040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tomatidine and Patchouli Alcohol as Inhibitors of SARS-CoV-2 Enzymes (3CLpro, PLpro and NSP15) by Molecular Docking and Molecular Dynamics Simulations.
    Zrieq R; Ahmad I; Snoussi M; Noumi E; Iriti M; Algahtani FD; Patel H; Saeed M; Tasleem M; Sulaiman S; Aouadi K; Kadri A
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repurposing nonnucleoside antivirals against SARS-CoV2 NSP12 (RNA dependent RNA polymerase): In silico-molecular insight.
    Begum F; Srivastava AK; Ray U
    Biochem Biophys Res Commun; 2021 Sep; 571():26-31. PubMed ID: 34303192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of phytochemicals as potential therapeutic agents that binds to Nsp15 protein target of coronavirus (SARS-CoV-2) that are capable of inhibiting virus replication.
    Kumar S; Kashyap P; Chowdhury S; Kumar S; Panwar A; Kumar A
    Phytomedicine; 2021 May; 85():153317. PubMed ID: 32943302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of promising antiviral drug candidates against non-structural protein 15 (NSP15) from SARS-CoV-2: an
    Khan RJ; Jha RK; Singh E; Jain M; Amera GM; Singh RP; Muthukumaran J; Singh AK
    J Biomol Struct Dyn; 2022 Jan; 40(1):438-448. PubMed ID: 32885740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp15 endoribonuclease.
    Canal B; Fujisawa R; McClure AW; Deegan TD; Wu M; Ulferts R; Weissmann F; Drury LS; Bertolin AP; Zeng J; Beale R; Howell M; Labib K; Diffley JFX
    Biochem J; 2021 Jul; 478(13):2465-2479. PubMed ID: 34198324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tipiracil binds to uridine site and inhibits Nsp15 endoribonuclease NendoU from SARS-CoV-2.
    Kim Y; Wower J; Maltseva N; Chang C; Jedrzejczak R; Wilamowski M; Kang S; Nicolaescu V; Randall G; Michalska K; Joachimiak A
    Commun Biol; 2021 Feb; 4(1):193. PubMed ID: 33564093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the hexamerization of SARS-CoV-2 endoribonuclease and modeling of RNA structures bound to the hexamer.
    Tran DP; Taira Y; Ogawa T; Misu R; Miyazawa Y; Kitao A
    Sci Rep; 2022 Mar; 12(1):3860. PubMed ID: 35264667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug designing against NSP15 of SARS-COV2 via high throughput computational screening and structural dynamics approach.
    Batool A; Bibi N; Amin F; Kamal MA
    Eur J Pharmacol; 2021 Feb; 892():173779. PubMed ID: 33275961
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Sharma A; Goyal S; Yadav AK; Kumar P; Gupta L
    J Biomol Struct Dyn; 2022 Jan; 40(1):86-100. PubMed ID: 32896226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A structural-based virtual screening and
    Ibrahim IM; Elfiky AA; Mahmoud SH; ElHefnawi M
    J Biomol Struct Dyn; 2024 Oct; 42(17):9145-9158. PubMed ID: 37615430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The coronavirus nsp15 endoribonuclease: A puzzling protein and pertinent antiviral drug target.
    Van Loy B; Stevaert A; Naesens L
    Antiviral Res; 2024 Aug; 228():105921. PubMed ID: 38825019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of nonstructural protein 15 of SARS-CoV-2 by golden spice: A computational insight.
    Singh R; Bhardwaj VK; Purohit R
    Cell Biochem Funct; 2022 Dec; 40(8):926-934. PubMed ID: 36203381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.
    Kumar Y; Singh H; Patel CN
    J Infect Public Health; 2020 Sep; 13(9):1210-1223. PubMed ID: 32561274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.